Why and when to screen for cardiovascular disease in healthy individuals
[...]guideline-based recommendations for individuals ≥70 years are lacking despite the fact that >80% of CVD deaths occur in this age group.13 14 Nevertheless, population-based screening and intervention based on clinical risk scores does not reduce all causes or cardiovascular mortality.15 16 Al...
Gespeichert in:
Veröffentlicht in: | Heart (British Cardiac Society) 2021-06, Vol.107 (12), p.1010-1017 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]guideline-based recommendations for individuals ≥70 years are lacking despite the fact that >80% of CVD deaths occur in this age group.13 14 Nevertheless, population-based screening and intervention based on clinical risk scores does not reduce all causes or cardiovascular mortality.15 16 Although these trials were performed before or in the beginning of modern cardiovascular preventive treatment with statins, the conclusion from these trials was that screening was not needed due to the quality of the general practitioners. [...]these studies do not address the potential of modern-day screening in primary prevention. [...]the majority of these studies were in those aged |
---|---|
ISSN: | 1355-6037 1468-201X |
DOI: | 10.1136/heartjnl-2019-316266 |